Literature DB >> 16033686

Alzheimer's amyloid immunotherapy: quo vadis?

Sam Gandy, Frank L Heppner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033686     DOI: 10.1016/S1474-4422(05)70124-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  1 in total

1.  Biological therapies: concepts and challenges.

Authors:  Markus Müller
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.